Concepedia

Oliver Bohnsack

OB

Statistics

Publications

4

Citations

3.4K

H-Index

4

Active since

2009

Affiliations

GlaxoSmithKline (United States)(Current)

Memorial Sloan Kettering Cancer Center

Oliver Bohnsack is an author at GlaxoSmithKline (United States) specializing in therapy response assessment, cancer immunotherapy, and medicine.

Publications per year

2009–2022

4

Publications

4

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Jedd D. Wolchok, Axel Hoos, Steven O’Day et al. · Clinical Cancer Research · 2009 · 3.2K citations

Medicine, Immunology, Oncology +17

Adaptation of the Immune Related Response Criteria: Irrecist

Oliver Bohnsack, Axel Hoos, Katarina Ludajic · Annals of Oncology · 2014 · 92 citations

Life Sciences, Immunology, Adaptive Immunity +9

Adaptation and modification of the immune related response criteria (IRRC): IrRECIST.

Oliver Bohnsack, Axel Hoos, Katarina Ludajic · Journal of Clinical Oncology · 2014 · 38 citations

Medicine, Oncology, Radiology +14

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

Juliane Manitz, Sandra P. D’Angelo, Andrea B. Apolo et al. · Journal for ImmunoTherapy of Cancer · 2022 · 34 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–4 of 4